Monopar Therapeutics Inc. buy Midas
Start price
24.10.20
/
50%
€4.00
Target price
04.11.21
-
Performance (%)
37.50%
End price
26.01.21
€5.50
Summary
This prediction ended on 26.01.21 with a price of €5.50. The BUY prediction by Midas for Monopar Therapeutics Inc. saw massive gains of 37.50%. Midas has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Monopar Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 3,59 % | 3,93 % | 15,38 % | 53,20 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % | 41,46 % | 91,09 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % | 48,95 % | 63,93 % |
| iShares S&P 500 | 4,14 % | 4,04 % | 31,59 % | 64,84 % |
Comments by Midas for this prediction
In the thread Monopar Therapeutics Inc. diskutieren
Buy Monopar Therapeutics Inc.